10-102110868-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001113407.3(LDB1):c.352+1G>A variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113407.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDB1 | ENST00000673968.1 | c.352+1G>A | splice_donor_variant, intron_variant | Intron 5 of 10 | NM_001113407.3 | ENSP00000501277.1 | ||||
LDB1 | ENST00000361198.9 | c.244+1G>A | splice_donor_variant, intron_variant | Intron 5 of 10 | 1 | ENSP00000354616.5 | ||||
LDB1 | ENST00000425280.2 | c.352+1G>A | splice_donor_variant, intron_variant | Intron 5 of 10 | 5 | ENSP00000392466.2 | ||||
LDB1 | ENST00000461873.5 | n.168+1G>A | splice_donor_variant, intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.